文献速递泌尿系感染前列腺增生与排尿功能障碍

低强度冲击波治疗慢性前列腺炎IIIb型/慢性盆腔疼痛综合征的双盲随机假对照试验

Evaluation of a low-intensity shockwave therapy for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2020-09-28

该前瞻性双盲假对照试验将45例CP/CPPS患者随机分为活性组(n=30,每次5000冲击波,能量通量密度0.1 mJ/mm2)和假组(n=15),每周一次共六次。结果显示LiST在NIH-CPSI总分、疼痛和QoL子域持续改善,疼痛域变化组间均差3.3(95%CI 1.8-4.7),且安全无副作用。

要点

  • LiST可显著且持续改善CP/CPPS患者的疼痛和生活质量
  • NIH-CPSI疼痛域变化组间均差3.3(95%CI 1.8-4.7)
  • LiST操作简便安全,无需麻醉且无副作用

核心结论

  • LiST似乎是CP/CPPS安全有效的治疗选择,可显著改善疼痛和生活质量。

研究设计与样本

  • 前瞻性、假对照、双盲随机研究,共纳入45例CP/CPPS患者,活性组30例,假组15例。
  • 活性组每次5000冲击波,能量通量密度0.1 mJ/mm2,假组使用外观相同的假探头,均每周一次共六次。

主要发现

  • LiST在NIH-CPSI总分、疼痛和QoL子域所有随访时间点均较假组有 clear and persistent 改善。
  • NIH-CPSI疼痛域(Q1-4)从基线至末次治疗后12周变化值组间均差为3.3(95%CI 1.8-4.7)。
  • NIH-CPSI排尿子域、IPSS、PSA和mpMRI-PIRADS评分两组间无差异。
  • 会阴部LiST操作简便安全,无需麻醉且无任何副作用。

临床怎么用

  • 对于CP/CPPS患者,可考虑使用LiST以改善疼痛和生活质量。
  • LiST无副作用且可重复治疗,可作为有前景的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently, there is no efficacious treatment method for chronic prostatitis type IIIb/chronic pelvic pain syndrome (CP/CPPS). Aim of the study was to investigate and compare the efficacy and safety of low-intensity shockwave therapy (LiST) vs. sham treatment in CP/CPPS patients. METHODS: Patients with CP/CPPS diagnosis were randomized in this prospective, sham-controlled, double-blind study either to the active groups (Group B, C) who received 5000 shockwaves per session with energy flux density 0.1 mJ/mm2 or to the sham group (Group A) who received 5000 shockwaves from a visually identical sham probe. All groups underwent six sessions (once/week). LiST effects on pain, micturition, quality of life (QoL), and erectile function were evaluated at 4, 12, and 24 weeks after treatment. The parameters were investigated using validated questionnaires. Uroflowmetry and post void residual calculation were performed at baseline and at 4- and 12-week FU visit. Prostate mpMRI and PSA measurement were performed at baseline and 12-week FU visit. RESULTS: Overall, 45 men were randomized to the active (n = 30) and sham groups (n = 15). Regarding impact of LiST in National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) total, pain, and QoL subdomains scores a clear and persistent in all FU timepoints improvement was found compared to sham treatment. NIH-CPSI urinary subdomain, International Prostate Symptom Score [IPSS], PSA, and mpMRI-PIRADS scores did not differ between the two groups. The mean difference between the LiST and sham group in the change of the NIH-CPSI pain-domain score (Q1-4) from baseline to 12 weeks after final treatment which was 3.3 (95% CI, 1.8, 4.7). Perineal LiST was easy and safe to perform without anesthesia or any side-effects. CONCLUSIONS: LiST seems to be a safe and effective treatment option for CP/CPPS, considerably improving pain and quality of life. Lack of any side-effects, and the potential for repetition make LiST a promising treatment choice for CP/CPPS patients.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Mykoniatis I, Kalyvianakis D, Zilotis F, et al. Evaluation of a low-intensity shockwave therapy for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial. Prostate Cancer Prostatic Dis. 2020. PMID: 32989261. doi:10.1038/s41391-020-00284-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。